Moreover, RNASET2 protein has been reported to be targeted for FBXO6 unbiquitin-dependent protein degradation in ovarian cancer suggesting additional regulatory mechanism contribute to RNASET2 protein turnover (66). This evidence concerns the gene FBXO6 and ovarian cancer.